Literature DB >> 3009597

Increased DHEAs levels in PCO syndrome: evidence for the existence of two subgroups of patients.

E Carmina, F Rosato, A Jannì.   

Abstract

In 49 patients affected by PCO syndrome the serum levels of dehydroepiandrosterone-sulphate (DHEAs) were determined and correlated with the clinical presentation and the endocrine pattern. Twenty-three patients (47%) had high DHEAs levels (h-DHEAs patients). They presented a milder clinical presentation (low incidence of amenorrhea) than PCO patients with normal DHEAs levels (n-DHEAs patients). In h-DHEAs patients the finding of a normal DHEAs response to ACTH and of slightly increased 170HP serum levels suggested that the elevation of serum DHEAs was not due to an adrenal enzymatic deficiency but to a tonic hyperstimulation of the adrenals. Two subgroups of h-DHEAs patients were identified: in the first subgroup, PRL and estrone levels were increased and probably explained the DHEAs hypersecretion; in the second subgroup, the endocrine pattern was very similar to that observed in n-DHEAs patients and a clear explanation for DHEAs increase was not found, although the possibility of an exaggerated secretion of some pituitary hormones with adrenal androgen stimulating activity must be considered.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009597     DOI: 10.1007/BF03348052

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  22 in total

1.  Adrenocortical hyperfunction in idiopathic hirsutism and the Stein-Leventhal syndrome.

Authors:  T F GALLAGHER; A KAPPAS; L HELLMAN; M B LIPSETT; O H PEARSON; C D WEST
Journal:  J Clin Invest       Date:  1958-06       Impact factor: 14.808

2.  The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man.

Authors:  E Nieschlag; D L Loriaux; H J Ruder; I R Zucker; M A Kirschner; M B Lipsett
Journal:  J Endocrinol       Date:  1973-04       Impact factor: 4.286

3.  Hyperprolactinemia in polycystic ovary syndrome.

Authors:  A A Luciano; F K Chapler; B M Sherman
Journal:  Fertil Steril       Date:  1984-05       Impact factor: 7.329

4.  Hirsutism: implications, etiology, and management.

Authors:  R Hatch; R L Rosenfield; M H Kim; D Tredway
Journal:  Am J Obstet Gynecol       Date:  1981-08-01       Impact factor: 8.661

5.  The endocrine pattern of late onset adrenal hyperplasia (21-hydroxylase deficiency).

Authors:  E Carmina; A M Gagliano; F Rosato; M Maggiore; A Jannì
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

6.  Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women.

Authors:  S P Glickman; R L Rosenfield; R M Bergenstal; J Helke
Journal:  J Clin Endocrinol Metab       Date:  1982-08       Impact factor: 5.958

7.  Oestrogen amplification of LH-RH response in the polycystic ovary syndrome and response to clomiphene.

Authors:  F R Kandeel; W R Butt; D R London; S S Lynch; R L Edwards; B T Rudd
Journal:  Clin Endocrinol (Oxf)       Date:  1978-11       Impact factor: 3.478

8.  [Hormone levels, celioscopy and ovarian histology in the hirsutism-anovulation syndrome].

Authors:  J Buvat; G Marcolin; M Buvat-Herbaut; J C Fourlinnie; A Racadot; P Quandalle; E Hermand; P Fossati
Journal:  Presse Med       Date:  1983-12-17       Impact factor: 1.228

9.  Effects of estrogens on adrenal 3 beta-hydroxysteroid dehydrogenase in ovariectomized women.

Authors:  D C Anderson; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1976-09       Impact factor: 5.958

10.  Plasma androgens in women with hyperprolactinaemic amenorrhoea.

Authors:  F Bassi; G Giusti; L Borsi; S Cattaneo; P Giannotti; G Forti; M Pazzagli; C Vigiani; M Serio
Journal:  Clin Endocrinol (Oxf)       Date:  1977-01       Impact factor: 3.478

View more
  7 in total

Review 1.  Adrenal hyperandrogenism in the pathophysiology of polycystic ovary syndrome.

Authors:  E Carmina; R A Lobo
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

2.  Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome.

Authors:  Kevin H Maas; Sandy Chuan; Evan Harrison; Heidi Cook-Andersen; Antoni J Duleba; R Jeffrey Chang
Journal:  Fertil Steril       Date:  2016-07-26       Impact factor: 7.329

3.  Prevalence of late-onset 11 beta-hydroxylase deficiency in hirsute patients.

Authors:  E Carmina; G Malizia; M Pagano; A Janni
Journal:  J Endocrinol Invest       Date:  1988-09       Impact factor: 4.256

4.  Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes.

Authors:  E Carmina; R A Lobo
Journal:  J Endocrinol Invest       Date:  2007-02       Impact factor: 4.256

Review 5.  The adrenal and polycystic ovary syndrome.

Authors:  Bulent O Yildiz; Ricardo Azziz
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514

Review 6.  MicroRNAs Related to Polycystic Ovary Syndrome (PCOS).

Authors:  Anja Elaine Sørensen; Marie Louise Wissing; Sofia Salö; Anne Lis Mikkelsen Englund; Louise Torp Dalgaard
Journal:  Genes (Basel)       Date:  2014-08-25       Impact factor: 4.096

7.  Adrenocortical steroid response to ACTH in different phenotypes of non-obese polycystic ovary syndrome.

Authors:  Nese Cinar; Ayla Harmanci; Duygu Yazgan Aksoy; Kadriye Aydin; Bulent Okan Yildiz
Journal:  J Ovarian Res       Date:  2012-12-07       Impact factor: 4.234

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.